Niva Bupa Health Insurance Company Ltd
Incorporated in 2008, Niva Bupa Health Insurance Ltd is a Tech driven leading health insurer in India.[1]
- Market Cap ₹ 14,589 Cr.
- Current Price ₹ 79.0
- High / Low ₹ 95.2 / 61.0
- Stock P/E 158
- Book Value ₹ 20.6
- Dividend Yield 0.00 %
- ROCE 7.45 %
- ROE 8.18 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 40.1% CAGR over last 5 years
Cons
- Stock is trading at 3.83 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Tax rate seems low
- Company has a low return on equity of 6.41% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Financial Services Financial Services Insurance General Insurance
Part of BSE 500 Nifty 500 BSE SmallCap BSE Allcap BSE Financial Services
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|
| 851 | 1,057 | 1,413 | 1,877 | 2,853 | 4,115 | 5,374 | 5,874 | |
| 880 | 1,094 | 1,435 | 2,328 | 3,183 | 4,228 | 5,296 | 5,793 | |
| Operating Profit | -29 | -37 | -22 | -451 | -330 | -113 | 78 | 81 |
| OPM % | -3% | -3% | -2% | -24% | -12% | -3% | 1% | 1% |
| 0 | 0 | 0 | 281 | 374 | 224 | 160 | 12 | |
| Interest | 3 | 4 | 6 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 16 | 21 | 22 | 27 | 32 | 29 | 25 | 0 |
| Profit before tax | -48 | -62 | -50 | -197 | 13 | 82 | 214 | 93 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | |
| -48 | -62 | -50 | -197 | 13 | 82 | 214 | 93 | |
| EPS in Rs | 1.17 | 0.51 | ||||||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 38% |
| 3 Years: | 42% |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 40% |
| 3 Years: | 45% |
| TTM: | -41% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 0% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 1% |
| 3 Years: | 6% |
| Last Year: | 8% |
Balance Sheet
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 981 | 1,126 | 1,350 | 1,409 | 1,511 | 1,700 | 1,827 | 1,846 |
| Reserves | -719 | -780 | -773 | -903 | -683 | 351 | 1,231 | 1,959 |
| 0 | 0 | 0 | 250 | 250 | 250 | 250 | 250 | |
| 737 | 891 | 1,322 | 1,983 | 2,799 | 3,891 | 6,452 | 6,595 | |
| Total Liabilities | 1,000 | 1,237 | 1,899 | 2,738 | 3,877 | 6,192 | 9,760 | 10,650 |
| 30 | 39 | 46 | 49 | 52 | 58 | 66 | 81 | |
| CWIP | 2 | 2 | 2 | 1 | 4 | 1 | 9 | 0 |
| Investments | 816 | 1,067 | 1,622 | 2,401 | 3,366 | 5,458 | 8,175 | 8,482 |
| 152 | 129 | 230 | 287 | 455 | 675 | 1,510 | 2,088 | |
| Total Assets | 1,000 | 1,237 | 1,899 | 2,738 | 3,877 | 6,192 | 9,760 | 10,650 |
Cash Flows
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 257 | 338 | 593 | 813 | 1,654 | |||
| -374 | -723 | -829 | -1,882 | -2,348 | |||
| 280 | 374 | 280 | 1,110 | 771 | |||
| Net Cash Flow | 164 | -12 | 43 | 41 | 78 |
Ratios
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | |||||||
| Days Payable | |||||||
| Cash Conversion Cycle | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Working Capital Days | -264 | -270 | -290 | -341 | -313 | -298 | -351 |
| ROCE % | -19% | -10% | -30% | 1% | 5% | 7% |
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
9 Jan - Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended December 31, 2025.
-
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
30 Dec - Allotment of 88,000 Equity shares under Niva Bupa Employee Stock Option Plan 2020.
- Closure of Trading Window 30 Dec
-
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015-ESG Rating
17 Dec - SES ESG assigned 65.3 ESG rating for FY2024-25; company did not engage the provider.
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 5 Dec 2025
Concalls
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT
Leading Insurance Company: Niva Bupa Health Insurance is one of the major players among private standalone health insurers in India. In FY25, the company held a gross direct premium income (GDPI) market share of ~5.31% in the health insurance segment and 17.59% among standalone private health insurers. Co received its license from the IRDAI on Feb 15, 2010 and commenced operations in Mar 2010.[1]